111 related articles for article (PubMed ID: 21789023)
1. Low-dose epirubicin inhibits ezrin-mediated metastatic behavior of breast cancer cells.
Ma L; Liu YP; Geng CZ; Xing LX; Zhang XH
Tumori; 2011; 97(3):400-5. PubMed ID: 21789023
[TBL] [Abstract][Full Text] [Related]
2. [Expression of Ezrin and E-cadherin in invasive ductal breast cancer and their correlations to lymphatic metastasis].
Li Q; Wu MF; Song AP; Wei JC; Xu G; Lu YP; Ma D
Ai Zheng; 2006 Mar; 25(3):363-6. PubMed ID: 16536996
[TBL] [Abstract][Full Text] [Related]
3. [Relationship of ezrin protein expression to the carcinogenesis and prognosis of infitrating breast ductal carcinoma].
Ma L; Zhang XH; Xing LX; Li YH; Wang XL; Wang YJ
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):279-83. PubMed ID: 18788632
[TBL] [Abstract][Full Text] [Related]
4. Role for ezrin in breast cancer cell chemotaxis to CCL5.
Li J; Tu Y; Wen J; Yao F; Wei W; Sun S
Oncol Rep; 2010 Oct; 24(4):965-71. PubMed ID: 20811677
[TBL] [Abstract][Full Text] [Related]
5. High expression and prognostic role of CAP1 and CtBP2 in breast carcinoma: associated with E-cadherin and cell proliferation.
Liu X; Yao N; Qian J; Huang H
Med Oncol; 2014 Mar; 31(3):878. PubMed ID: 24522810
[TBL] [Abstract][Full Text] [Related]
6. CD44/cellular prion protein interact in multidrug resistant breast cancer cells and correlate with responses to neoadjuvant chemotherapy in breast cancer patients.
Cheng Y; Tao L; Xu J; Li Q; Yu J; Jin Y; Chen Q; Xu Z; Zou Q; Liu X
Mol Carcinog; 2014 Sep; 53(9):686-97. PubMed ID: 23681900
[TBL] [Abstract][Full Text] [Related]
7. Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer.
Ghaffari A; Hoskin V; Turashvili G; Varma S; Mewburn J; Mullins G; Greer PA; Kiefer F; Day AG; Madarnas Y; SenGupta S; Elliott BE
Breast Cancer Res; 2019 Jan; 21(1):12. PubMed ID: 30678714
[TBL] [Abstract][Full Text] [Related]
8. Baicalein mediates inhibition of migration and invasiveness of skin carcinoma through Ezrin in A431 cells.
Wu B; Li J; Huang D; Wang W; Chen Y; Liao Y; Tang X; Xie H; Tang F
BMC Cancer; 2011 Dec; 11():527. PubMed ID: 22204275
[TBL] [Abstract][Full Text] [Related]
9. Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.
Mitra A; Fillmore RA; Metge BJ; Rajesh M; Xi Y; King J; Ju J; Pannell L; Shevde LA; Samant RS
Breast Cancer Res; 2008; 10(2):R22. PubMed ID: 18328103
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the tracing effect of carbon nanoparticle and carbon nanoparticle-epirubicin suspension in axillary lymph node dissection for breast cancer treatment.
Du J; Zhang Y; Ming J; Liu J; Zhong L; Liang Q; Fan L; Jiang J
World J Surg Oncol; 2016 Jun; 14(1):164. PubMed ID: 27335011
[TBL] [Abstract][Full Text] [Related]
11. [Invasive ductal carcinoma and chronic lymphocytic leukemia: a unique case of collision tumor in breast].
Liang L; Fu J; Liu YL; Xing W; Leng H; Zhang HW
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):706-7. PubMed ID: 22321555
[No Abstract] [Full Text] [Related]
12. [Impact of preoperative lymphatic chemotherapy on relapse and metastasis of breast cancer and its mechanism].
Wu WJ; Zeng J; Lu YF; Jiang WZ; Chen L; Pan CE
Ai Zheng; 2005 Dec; 24(12):1537-41. PubMed ID: 16351809
[TBL] [Abstract][Full Text] [Related]
13. [Expression and clinical significance of LRP16 gene in human breast cancer].
Liao DX; Han WD; Zhao YL; Pu YD; Mu YM; Luo CH; Li XH
Ai Zheng; 2006 Jul; 25(7):866-70. PubMed ID: 16831279
[TBL] [Abstract][Full Text] [Related]
14. Ezrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cells.
Mak H; Naba A; Varma S; Schick C; Day A; SenGupta SK; Arpin M; Elliott BE
BMC Cancer; 2012 Mar; 12():82. PubMed ID: 22397367
[TBL] [Abstract][Full Text] [Related]
15. Increase in ezrin expression from benign to malignant breast tumours.
Gschwantler-Kaulich D; Natter C; Steurer S; Walter I; Thomas A; Salama M; Singer CF
Cell Oncol (Dordr); 2013 Dec; 36(6):485-91. PubMed ID: 24129929
[TBL] [Abstract][Full Text] [Related]
16. Plasma CCL5 promotes EMT-medicated epirubicin-resistance in locally advanced breast cancer.
Ma G; Huang H; Li M; Li L; Kong P; Zhu Y; Xia T; Wang S
Cancer Biomark; 2018; 22(3):405-415. PubMed ID: 29758926
[TBL] [Abstract][Full Text] [Related]
17. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells.
Li Q; Wu M; Wang H; Xu G; Zhu T; Zhang Y; Liu P; Song A; Gang C; Han Z; Zhou J; Meng L; Lu Y; Wang S; Ma D
Cancer Lett; 2008 Mar; 261(1):55-63. PubMed ID: 18155831
[TBL] [Abstract][Full Text] [Related]
18. Nudix-type motif 2 in human breast carcinoma: a potent prognostic factor associated with cell proliferation.
Oka K; Suzuki T; Onodera Y; Miki Y; Takagi K; Nagasaki S; Akahira J; Ishida T; Watanabe M; Hirakawa H; Ohuchi N; Sasano H
Int J Cancer; 2011 Apr; 128(8):1770-82. PubMed ID: 20533549
[TBL] [Abstract][Full Text] [Related]
19. Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer.
Song J; Bai J; Yang W; Gabrielson EW; Chan DW; Zhang Z
Histopathology; 2007 Jul; 51(1):40-53. PubMed ID: 17593079
[TBL] [Abstract][Full Text] [Related]
20. Ectopic expression of RhoBTB2 inhibits migration and invasion of human breast cancer cells.
Ling LJ; Lu C; Zhou GP; Wang S
Cancer Biol Ther; 2010 Dec; 10(11):1115-22. PubMed ID: 20930524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
